IL18 and cancer: However, IL‐18 is overexpressed in tumour tissues and its expression correlates with tumour progression, metastasis and poor prognosis in some cancers, such as PDAC, extranodal natural killer/T‐cell lymphoma and renal cell carcinoma.20, 21, 22